
Deep Brain Stimulation Devices Market : Estimated to Observe Significant Growth to Reach $2,802.6 million by 2026

Deep Brain Stimulation Devices Market
The global deep brain stimulation devices market valued at $881.9 million in 2018, and projected to reach $2,802.6 million by 2026, registering a 15.5% CAGR .
PORTLAND, OR, UNITED STATES, June 2, 2023/EINPresswire.com/ -- The Deep brain stimulation (DBS) devices market is a growing market that involves the use of implanted neurostimulation devices for the treatment of neurological and movement disorders, such as Parkinsonโs disease, essential tremor, and dystonia, among others. This market includes a variety of companies that offer DBS products and services, such as medical device manufacturers and healthcare providers.
The global deep brain stimulation devices market was valued at $881.9 million in 2018, and is projected to reach $2,802.6 million by 2026, registering a CAGR of 15.5%.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ@ https://www.alliedmarketresearch.com/request-sample/1477
The types of DBS devices available on the market include rechargeable and non-rechargeable devices, as well as directional and non-directional electrodes. These devices can be used to provide targeted stimulation to specific areas of the brain, improving symptoms and quality of life for patients with neurological and movement disorders.
With the growing prevalence of neurological disorders and the need for effective treatment options, the DBS devices market is expected to continue its growth trajectory in the coming years.
Increasing demand for minimally invasive surgery, adoption of technologically advanced products, and aging population drive the brain stimulation devices market as they are more susceptible to neurological disorders such as epilepsy, Parkinsonโs disease, Alzheimerโs disease, and chronic pain. Increase in the prevalence of lifestyle diseases such as depression and chronic pain, increase in the number of neurological disorders and investment in neurological R&D are the factors driving the growth of the global deep brain stimulation devices market.
๐๐๐ฒ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:
The Parkinsonโs disease segment captured the largest market share in 2018 and is expected to maintain this lead during the forecast period. Furthermore, the segment is expected to exhibit the fastest growth rate during the forecast period due to the increase in the prevalence of Parkinsonโs worldwide.
According to end-user, the hospital segment holds the highest deep brain stimulation device market share in 2018. In addition, this segment is expected to witness the fastest growth during the forecast period, as the number has increased. Hospitals around the world. Furthermore, neurological disorders are diagnosed and treated by professional neurologists using advanced equipment, which are available in specialized hospitals.
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐๐ ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ) @ https://www.alliedmarketresearch.com/deep-brain-stimulation-devices-market
North America accounted for the major share of the deep brain stimulation devices market size and is expected to continue this trend, owing to higher number of R&D activities, presence of skilled technicians, and wide availability of technologically advanced deep brain stimulation devices. Moreover, surge in prevalence of various neurological disorders is another factor that boost the deep brain stimulation devices market in the region.
๐๐๐๐ฉ ๐๐ซ๐๐ข๐ง ๐๐ญ๐ข๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
โข Aleva Neurotherapeutics SA,
โข Boston Scientific Corporation,
โข Functional Neuromodulation Ltd.,
โข Beijing PINS Medical Co., Ltd.,
โข Medtronic plc,
โข NeuroPace Inc.,
โข Nevro Corporation,
โข Neuronetics Inc.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ@ https://www.alliedmarketresearch.com/purchase-enquiry/1477
๐๐๐ฒ ๐ ๐ข๐ง๐๐ข๐ง๐ ๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
โข This report entails a detailed quantitative analysis along with the current global deep brain stimulation devices market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
โข The deep brain stimulation devices market forecast is studied from 2019 to 2026.
โข The deep brain stimulation devices market size and estimations are based on a comprehensive analysis of key developments in the deep brain stimulation devices industry.
โข A qualitative analysis based on innovative products facilitates strategic business planning.
โข The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:
Gene Synthesis Market: https://www.alliedmarketresearch.com/gene-synthesis-market-A39015
Mobile Tomography Market: https://www.alliedmarketresearch.com/mobile-tomography-market-A31901
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
+ 1-800-792-5285
email us here

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release